- Home
- EHTH vs ATAI Comparison
EHTH vs ATAI Comparison
Compare EHTH & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- ATAI
- Stock Information
- Founded
- EHTH 1997
- ATAI 2018
- Country
- EHTH United States
- ATAI Germany
- Employees
- EHTH N/A
- ATAI N/A
- Industry
- EHTH Specialty Insurers
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- ATAI Health Care
- Exchange
- EHTH Nasdaq
- ATAI Nasdaq
- Market Cap
- EHTH 176.1M
- ATAI 282.6M
- IPO Year
- EHTH 2006
- ATAI 2021
- Fundamental
- Price
- EHTH $5.37
- ATAI $1.41
- Analyst Decision
- EHTH Buy
- ATAI Strong Buy
- Analyst Count
- EHTH 4
- ATAI 3
- Target Price
- EHTH $6.75
- ATAI $10.50
- AVG Volume (30 Days)
- EHTH 367.7K
- ATAI 1.4M
- Earning Date
- EHTH 05-07-2025
- ATAI 05-19-2025
- Dividend Yield
- EHTH N/A
- ATAI N/A
- EPS Growth
- EHTH N/A
- ATAI N/A
- EPS
- EHTH N/A
- ATAI N/A
- Revenue
- EHTH $552,565,000.00
- ATAI $308,000.00
- Revenue This Year
- EHTH $1.38
- ATAI $65.58
- Revenue Next Year
- EHTH $8.81
- ATAI N/A
- P/E Ratio
- EHTH N/A
- ATAI N/A
- Revenue Growth
- EHTH 17.04
- ATAI N/A
- 52 Week Low
- EHTH $3.58
- ATAI $1.03
- 52 Week High
- EHTH $11.36
- ATAI $2.57
- Technical
- Relative Strength Index (RSI)
- EHTH 42.06
- ATAI 44.57
- Support Level
- EHTH $4.36
- ATAI $1.36
- Resistance Level
- EHTH $7.09
- ATAI $1.54
- Average True Range (ATR)
- EHTH 0.57
- ATAI 0.09
- MACD
- EHTH 0.01
- ATAI -0.00
- Stochastic Oscillator
- EHTH 37.00
- ATAI 0.00
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.